Author: healthadmin

Astronomers say a new study confirms that the universe is still expanding at an accelerating rate, resolving a recent challenge to one of the most important discoveries in modern cosmology. The debate began in late 2025, when a group of astronomers published research suggesting that evidence for dark energy, a mysterious phenomenon thought to be driving the accelerated expansion of the universe, was weakening. Their analysis raises the possibility that the expansion of the universe is no longer accelerating. The researchers argued that the standard approach of measuring the expansion of the universe using supernovae, the explosive deaths of stars,…

Non-invasive prenatal testing (NIPT) has revolutionized prenatal diagnosis by allowing the detection of many genetic problems in the fetus, but it currently has limitations and therefore misses many genetic causes of abnormalities. But new technology being presented today (Saturday) at the annual meeting of the European Society of Human Genetics, called non-invasive fetal sequencing (NIFS), will simultaneously screen for almost 23,000 genes and all the conditions currently captured by NIPT, regardless of the presence or absence of previously detected fetal abnormalities. Christopher Whelan, a senior computational scientist working in the lab of Dr. Michael Tarkowski at the Massachusetts Institute of…

Women with HIV most often die from preventable trauma-related conditions, such as drug use or mental illness, rather than the virus itself. But these leading causes are largely missing from official death records, according to a new study from the University of California, San Francisco. This study is the first to compare death certificates with causes of death determined by doctors, nurses, social workers, and pharmacists who knew them. Although HIV was listed as the cause of death in 68% of cases, health care providers found that it was involved in only 15% of cases. Meanwhile, health care providers identified…

Anticancer drugs can shrink rapidly growing tumors. However, sometimes a small number of tumor cells survive. These “persistent” cells seed new tumors and force cancer patients into difficult cycles of testing and treatment. The problem is that persistent cells are rare, making up about 1 in 1,000 tumor cells, and they are difficult to find because they are genetically identical to the tumor. Moreover, their tenacity may be temporary, and by the time scientists can transfer them to petri dishes, the properties that helped them survive may have faded. To find a way to overcome them, researchers at the University…

The U.S. Food and Drug Administration (FDA) has approved the immunotherapy pembrolizumab and the HIF-2α inhibitor velzutifan as adjuvant therapy for adult patients with clear cell renal cell carcinoma (ccRCC) who are at intermediate to high risk of recurrence after nephrectomy, with or without resection of metastatic disease. This approval is based on results from the Phase 3 LITESPARK-022 trial led by Toni Choeiri, MD, director of the Lanc Genitourinary Oncology Center at Dana-Farber Cancer Institute. This approval establishes this combination of pembrolizumab and belzutifan as a new adjuvant treatment option for patients with ccRCC who are at high risk…

Malcolm Brenner, an internationally recognized physician-scientist known for his leadership in cell and gene therapy, has been named director of the newly created Houston Methodist Cell and Gene Therapy Center. The center will bring together scientists and clinicians from Houston Methodist’s academic research and clinical care settings to discover and advance new treatments for a wide range of diseases. Its collaborative approach integrates expertise across disciplines and accelerates the translation of promising preclinical discoveries into clinical evaluation. The center will also support the development of both gene and cell therapies designed to address congenital and acquired diseases throughout the body.…

For many people who suffer from depression, the condition means more than just feeling down, it also means a loss of motivation and difficulty finding enjoyment in activities they used to enjoy. A study conducted at Lund University and the Skåne region in Sweden shows that a drug used to treat Parkinson’s disease can be used as an add-on therapy to reduce symptoms in some patients with treatment-resistant depression.This research natural medicine. Researchers from Lund University and the Skåne Region Psychiatric Service have identified a potential new treatment for symptoms associated with depression, which involve a reduced ability to feel…

We tend to think that emotional words are more likely to grab our attention. It can seem impossible to ignore the insults shouted in a crowded room or the disturbing phrases heard on the television. However, a new study has been published psychological science This suggests that the opposite may occur before words reach consciousness. Researchers at the Hebrew University of Jerusalem found that when people are concentrating on a visual task, they are less likely to consciously notice negative spoken words than neutral ones. The findings provide new insights into how the brain decides what information enters consciousness and…

Primary hyperparathyroidism (PHPT) is a common endocrine disorder characterized by excessive secretion of parathyroid hormone (PTH). Some patients experience significant bone loss and increased fracture risk, while others with similar hormone levels maintain relatively healthy bones. So far, the reasons for this variation remain unclear. Now, a new study led by Professor Roberto Pacifici has been published in the journal May 25, 2026. bone researchResearchers investigated whether the gut microbiota could explain differences in skeletal outcomes among PHPT patients. The research team analyzed stool samples, bone density measurements, and immune cell profiles from 50 patients with PHPT. Their findings revealed…

Carefully designed metal-free carbon monoxide prodrugs could help prevent the spread of some of the deadliest cancers, Weill Cornell Medicine researchers say. A recent preclinical study published in Advanced Science proposes a new strategy to potentially reduce recurrence of pancreatic and triple-negative breast cancer in patients who initially respond to treatment. Even after surgery or chemotherapy, microscopic cancer cells often survive and form new tumors in distant organs. Researchers have long sought treatments that can safely block this process. “We are developing a unique approach to blocking metastases using metal-free prodrugs designed to release low levels of carbon monoxide in…